Tizanidine
产品说明书
 |
同义名 : | - |
| CAS号 : | 51322-75-9 | |
| 货号 : | A456347 | |
| 分子式 : | C9H8ClN5S | |
| 纯度 : | 99% | |
| 分子量 : | 253.71 | |
| MDL号 : | MFCD00865192 | |
| 存储条件： |
Pure form Keep in dark place, inert atmosphere, store in freezer, under -20°C In solvent -20°C:3-6个月-80°C:12个月 |
|
| 溶解度 : |
DMSO: 20 mg/mL(78.83 mM)，配合低频超声，并调节pH至3，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO |
|
| 动物实验配方： |
| 生物活性 | |||
|---|---|---|---|
| 描述 | Tizanidine is an α2-adrenergic receptor agonist and inhibits neurotransmitter release from CNS noradrenergic neurons. | ||
| 临床研究 | |||||
|---|---|---|---|---|---|
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT02403687 | - | Completed | - | - | |
| NCT01753882 | Spinal Cord Injury | Phase 1 | Unknown | July 2017 | United States, Illinois ... 展开 >> Rehabilitation Institute of Chicago Chicago, Illinois, United States, 60611 收起 << |
| NCT01547234 | - | Completed | - | Israel ... 展开 >> Multiple Sclerosis Center Carmel Medical Center Haifa, Israel 收起 << | |
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
3.94mL 0.79mL 0.39mL |
19.71mL 3.94mL 1.97mL |
39.42mL 7.88mL 3.94mL |
| 参考文献 |
|---|